Intuitive Surgical, Inc. (NASDAQ:ISRG) VP Jamie Samath sold 242 shares of the stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $949.01, for a total transaction of $229,660.42. Following the completion of the sale, the vice president now owns 23 shares of the company’s stock, valued at approximately $21,827.23. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Jamie Samath also recently made the following trade(s):

  • On Monday, June 5th, Jamie Samath sold 1,946 shares of Intuitive Surgical stock. The shares were sold at an average price of $921.26, for a total transaction of $1,792,771.96.
  • On Friday, May 5th, Jamie Samath sold 48 shares of Intuitive Surgical stock. The shares were sold at an average price of $850.00, for a total transaction of $40,800.00.

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) traded down 0.45% during trading on Tuesday, reaching $944.92. 356,480 shares of the company’s stock were exchanged. The stock has a 50-day moving average price of $935.86 and a 200 day moving average price of $809.08. Intuitive Surgical, Inc. has a 12 month low of $610.71 and a 12 month high of $974.66. The firm has a market cap of $35.10 billion, a price-to-earnings ratio of 45.26 and a beta of 0.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $5.79 by $0.16. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The firm had revenue of $756.20 million during the quarter, compared to analyst estimates of $724.51 million. During the same quarter in the prior year, the firm earned $5.62 EPS. The business’s revenue for the quarter was up 12.8% compared to the same quarter last year. On average, analysts forecast that Intuitive Surgical, Inc. will post $23.86 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This report was originally reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/07/25/jamie-samath-sells-242-shares-of-intuitive-surgical-inc-isrg-stock.html.

Several large investors have recently added to or reduced their stakes in the stock. Brown Advisory Securities LLC raised its stake in Intuitive Surgical by 1.4% in the first quarter. Brown Advisory Securities LLC now owns 2,247 shares of the medical equipment provider’s stock valued at $1,722,000 after buying an additional 31 shares during the last quarter. Vident Investment Advisory LLC raised its stake in Intuitive Surgical by 137.0% in the first quarter. Vident Investment Advisory LLC now owns 9,572 shares of the medical equipment provider’s stock valued at $7,337,000 after buying an additional 5,534 shares during the last quarter. Marshall Wace North America L.P. acquired a new stake in Intuitive Surgical during the first quarter valued at approximately $9,596,000. Credit Suisse AG raised its stake in Intuitive Surgical by 12.1% in the first quarter. Credit Suisse AG now owns 111,246 shares of the medical equipment provider’s stock valued at $85,268,000 after buying an additional 11,965 shares during the last quarter. Finally, Forte Capital LLC ADV raised its stake in Intuitive Surgical by 10.6% in the first quarter. Forte Capital LLC ADV now owns 2,562 shares of the medical equipment provider’s stock valued at $1,964,000 after buying an additional 245 shares during the last quarter. 97.56% of the stock is owned by hedge funds and other institutional investors.

ISRG has been the subject of several analyst reports. Royal Bank Of Canada increased their target price on shares of Intuitive Surgical from $720.00 to $770.00 and gave the company a “sector perform” rating in a report on Monday, April 17th. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $860.00 target price for the company in a report on Tuesday, April 18th. Barclays PLC reiterated a “buy” rating and issued a $830.00 target price (up previously from $800.00) on shares of Intuitive Surgical in a report on Wednesday, April 19th. Wedbush increased their target price on shares of Intuitive Surgical from $800.00 to $835.00 and gave the company an “outperform” rating in a report on Wednesday, April 19th. Finally, Canaccord Genuity reiterated a “buy” rating and issued a $870.00 target price (up previously from $800.00) on shares of Intuitive Surgical in a report on Wednesday, April 19th. Six equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $972.39.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.